This is a Validated Antibody Database (VAD) review about human SSTR2, based on 16 published articles (read how Labome selects the articles), using SSTR2 antibody in all methods. It is aimed to help Labome visitors find the most suited SSTR2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Knockout validation
Santa Cruz Biotechnology
mouse monoclonal (A-8)
  • immunohistochemistry; human; 1:400; loading ...; fig s3c
  • immunohistochemistry knockout validation; mouse; fig s3d
Santa Cruz Biotechnology SSTR2 antibody (Santa Cruz Biotechnology, sc-365502) was used in immunohistochemistry on human samples at 1:400 (fig s3c) and in immunohistochemistry knockout validation on mouse samples (fig s3d). Cell Rep (2019) ncbi
Abcam
domestic rabbit monoclonal (UMB1)
  • immunohistochemistry; mouse; 1:2000; loading ...; fig 6a
Abcam SSTR2 antibody (Abcam, ab134152) was used in immunohistochemistry on mouse samples at 1:2000 (fig 6a). J Alzheimers Dis (2021) ncbi
domestic rabbit monoclonal (UMB1)
  • immunohistochemistry; human; loading ...; fig 1c
Abcam SSTR2 antibody (Abcam, ab134152) was used in immunohistochemistry on human samples (fig 1c). EJNMMI Res (2021) ncbi
domestic rabbit monoclonal (UMB1)
  • immunohistochemistry; human; 1:400; fig 4c
Abcam SSTR2 antibody (Abcam, ab134152) was used in immunohistochemistry on human samples at 1:400 (fig 4c). Aging (Albany NY) (2020) ncbi
domestic rabbit monoclonal (UMB1)
  • immunocytochemistry; mouse; loading ...; fig 2a
  • western blot; mouse; loading ...; fig 2d
Abcam SSTR2 antibody (Abcam, ab134152) was used in immunocytochemistry on mouse samples (fig 2a) and in western blot on mouse samples (fig 2d). Endocrine (2020) ncbi
domestic rabbit monoclonal (UMB1)
  • immunohistochemistry; human; 1:50; loading ...; tbl 5,
Abcam SSTR2 antibody (Abcam, UMB1) was used in immunohistochemistry on human samples at 1:50 (tbl 5, ). Medicine (Baltimore) (2020) ncbi
domestic rabbit monoclonal (UMB1)
  • immunohistochemistry - paraffin section; human; 1:400; loading ...; fig 1a
Abcam SSTR2 antibody (Abcam, ab134152) was used in immunohistochemistry - paraffin section on human samples at 1:400 (fig 1a). BMC Cancer (2020) ncbi
domestic rabbit monoclonal (UMB1)
  • immunocytochemistry; mouse; loading ...; fig 1a
Abcam SSTR2 antibody (Abcam, ab134152) was used in immunocytochemistry on mouse samples (fig 1a). J Cell Biol (2020) ncbi
domestic rabbit monoclonal (UMB1)
  • immunohistochemistry - paraffin section; human; 1:100; fig 1j
Abcam SSTR2 antibody (Abcam, ab134152) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 1j). Sci Rep (2017) ncbi
domestic rabbit monoclonal (UMB1)
  • other; human; 1:100; loading ...; fig 2
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 4
  • western blot; human; 1:1000
Abcam SSTR2 antibody (Abcam, ab134152) was used in other on human samples at 1:100 (fig 2), in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4) and in western blot on human samples at 1:1000. PLoS ONE (2017) ncbi
domestic rabbit monoclonal (UMB1)
  • immunohistochemistry - paraffin section; mouse
  • immunocytochemistry; mouse; fig 1b
  • western blot; mouse; loading ...; fig 1a
In order to present multimodal somatostatin receptor theranostics via [(64)Cu]Cu-/[(177)Lu]Lu-DOTA-(Tyr(3))octreotate and AN-238 in a mouse pheochromocytoma model, Abcam SSTR2 antibody (Abcam, ab134152) was used in immunohistochemistry - paraffin section on mouse samples , in immunocytochemistry on mouse samples (fig 1b) and in western blot on mouse samples (fig 1a). Theranostics (2016) ncbi
domestic rabbit monoclonal (UMB1)
  • immunohistochemistry; mouse; 1:250; fig 4
In order to evaluate the antitumor activity of the pan-HDAC inhibitor, panobinostat, in mice, Abcam SSTR2 antibody (Abcam, 134152) was used in immunohistochemistry on mouse samples at 1:250 (fig 4). Int J Cancer (2016) ncbi
domestic rabbit monoclonal (UMB1)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...
In order to assess the relationship between the results of the octreotide test and somatostatin receptor 2 expression in insulinoma patients to predict insulinomas in Japanese patients, Abcam SSTR2 antibody (Abcam, UMB1) was used in immunohistochemistry - paraffin section on human samples at 1:100. Endocr J (2016) ncbi
domestic rabbit monoclonal (UMB1)
  • immunohistochemistry - paraffin section; human; 1:250; fig 1
In order to discuss the use of a theranostic combination to treat pediatric patients with refractory neuroblastoma, Abcam SSTR2 antibody (Abcam, UMB1) was used in immunohistochemistry - paraffin section on human samples at 1:250 (fig 1). J Pediatr Hematol Oncol (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (A-8)
  • immunohistochemistry; human; 1:400; loading ...; fig s3c
  • immunohistochemistry knockout validation; mouse; fig s3d
Santa Cruz Biotechnology SSTR2 antibody (Santa Cruz Biotechnology, sc-365502) was used in immunohistochemistry on human samples at 1:400 (fig s3c) and in immunohistochemistry knockout validation on mouse samples (fig s3d). Cell Rep (2019) ncbi
Invitrogen
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:500; loading ...; fig 1g
In order to determine the expression of somatostatin receptors in Von Hippel-Lindau-associated hemangioblastomas, Invitrogen SSTR2 antibody (Thermo Fischer, PA3-109) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1g). Sci Rep (2017) ncbi
MilliporeSigma
domestic rabbit polyclonal
  • immunocytochemistry; human; 1:100; fig s1
MilliporeSigma SSTR2 antibody (Sigma, HPA007264) was used in immunocytochemistry on human samples at 1:100 (fig s1). J Clin Endocrinol Metab (2016) ncbi
Articles Reviewed
  1. Sakakibara Y, Hirota Y, Ibaraki K, Takei K, Chikamatsu S, Tsubokawa Y, et al. Widespread Reduced Density of Noradrenergic Locus Coeruleus Axons in the App Knock-In Mouse Model of Amyloid-β Amyloidosis. J Alzheimers Dis. 2021;82:1513-1530 pubmed publisher
  2. Meester E, De Blois E, Krenning B, van der Steen A, Norenberg J, van Gaalen K, et al. Autoradiographical assessment of inflammation-targeting radioligands for atherosclerosis imaging: potential for plaque phenotype identification. EJNMMI Res. 2021;11:27 pubmed publisher
  3. Chen Y, Gao H, Liu Q, Xie W, Li B, Cheng S, et al. Functional characterization of DLK1/MEG3 locus on chromosome 14q32.2 reveals the differentiation of pituitary neuroendocrine tumors. Aging (Albany NY). 2020;13:1422-1439 pubmed publisher
  4. Alshafie W, Pan Y, Kreienkamp H, Stroh T. Characterization of agonist-dependent somatostatin receptor subtype 2 trafficking in neuroendocrine cells. Endocrine. 2020;: pubmed publisher
  5. Li D, Zhu R, Zhou L, Zhong D. Clinical, histopathologic, subtype, and immunohistochemical analysis of jaw phosphaturic mesenchymal tumors. Medicine (Baltimore). 2020;99:e19090 pubmed publisher
  6. Nielsen K, Binderup T, Langer S, Kjaer A, Knigge P, Grøndahl V, et al. P53, Somatostatin receptor 2a and Chromogranin A immunostaining as prognostic markers in high grade gastroenteropancreatic neuroendocrine neoplasms. BMC Cancer. 2020;20:27 pubmed publisher
  7. Alshafie W, Francis V, Bednarz K, Pan Y, Stroh T, McPherson P. Regulated resurfacing of a somatostatin receptor storage compartment fine-tunes pituitary secretion. J Cell Biol. 2020;219: pubmed publisher
  8. Saponaro C, Gmyr V, Thevenet J, Moerman E, Delalleau N, Pasquetti G, et al. The GLP1R Agonist Liraglutide Reduces Hyperglucagonemia Induced by the SGLT2 Inhibitor Dapagliflozin via Somatostatin Release. Cell Rep. 2019;28:1447-1454.e4 pubmed publisher
  9. Yuan H, Krawczyk E, Blancato J, Albanese C, Zhou D, Wang N, et al. HPV positive neuroendocrine cervical cancer cells are dependent on Myc but not E6/E7 viral oncogenes. Sci Rep. 2017;7:45617 pubmed publisher
  10. Hasegawa K, Kudoh S, Ito T. Somatostatin receptor staining in FFPE sections using a ligand derivative dye as an alternative to immunostaining. PLoS ONE. 2017;12:e0172030 pubmed publisher
  11. Sizdahkhani S, Feldman M, Piazza M, Ksendzovsky A, Edwards N, Ray Chaudhury A, et al. Somatostatin receptor expression on von Hippel-Lindau-associated hemangioblastomas offers novel therapeutic target. Sci Rep. 2017;7:40822 pubmed publisher
  12. Fotouhi O, Kjellin H, Larsson C, Hashemi J, Barriuso J, Juhlin C, et al. Proteomics Suggests a Role for APC-Survivin in Response to Somatostatin Analog Treatment of Neuroendocrine Tumors. J Clin Endocrinol Metab. 2016;101:3616-3627 pubmed
  13. Ullrich M, Bergmann R, Peitzsch M, Zenker E, Cartellieri M, Bachmann M, et al. Multimodal Somatostatin Receptor Theranostics Using [(64)Cu]Cu-/[(177)Lu]Lu-DOTA-(Tyr(3))octreotate and AN-238 in a Mouse Pheochromocytoma Model. Theranostics. 2016;6:650-65 pubmed publisher
  14. Waldeck K, Cullinane C, Ardley K, Shortt J, Martin B, Tothill R, et al. Long term, continuous exposure to panobinostat induces terminal differentiation and long term survival in the TH-MYCN neuroblastoma mouse model. Int J Cancer. 2016;139:194-204 pubmed publisher
  15. Nakamura A, Mitsuhashi T, Takano Y, Miyoshi H, Kameda H, Nomoto H, et al. Usefulness of the octreotide test in Japanese patients for predicting the presence/absence of somatostatin receptor 2 expression in insulinomas. Endocr J. 2016;63:135-42 pubmed publisher
  16. Kong G, Hofman M, Murray W, Wilson S, Wood P, Downie P, et al. Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma. J Pediatr Hematol Oncol. 2016;38:87-96 pubmed publisher